Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

A fat-blocking drug could help to fight metastatic cancer

The antibody drug is moving closer to being tested in people with advanced stages of cancer.
  1. Elie Dolgin

    1. Elie Dolgin is a science journalist in Somerville, Massachusetts.

    View author publications

    You can also search for this author in PubMed  Google Scholar

ONA Therapeutics in Barcelona, Spain, spun off from the Institute for Research in Biomedicine, Barcelona, and the Catalan Institution for Research and Advanced Studies, Barcelona, in 2019.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-023-01648-z

This article is part of Nature Outlook: The Spinoff Prize 2023, an editorially independent supplement produced with the financial support of third parties. About this content.

References

  1. Pascual, G. et al. Nature 541, 41–45 (2017).

    Article  PubMed  Google Scholar 

  2. Pascual, G. et al. Nature 599, 485–490 (2021).

    Article  PubMed  Google Scholar 

  3. Landberg, N. et al. Haematologica 103, 447–455 (2018).

    Article  PubMed  Google Scholar 

  4. Feng, W. W. et al. Cell Rep. 29, 3405–3420 (2019).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links